Form 8-K - Current report:
SEC Accession No. 0001558370-25-008817
Filing Date
2025-06-24
Accepted
2025-06-24 10:15:15
Documents
13
Period of Report
2025-06-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K dwtx-20250618x8k.htm   iXBRL 8-K 85377
2 EX-10.1 dwtx-20250618xex10d1.htm EX-10.1 105496
  Complete submission text file 0001558370-25-008817.txt   327604

Data Files

Seq Description Document Type Size
3 EX-101.SCH dwtx-20250618.xsd EX-101.SCH 3436
4 EX-101.LAB dwtx-20250618_lab.xml EX-101.LAB 15927
5 EX-101.PRE dwtx-20250618_pre.xml EX-101.PRE 10042
15 EXTRACTED XBRL INSTANCE DOCUMENT dwtx-20250618x8k_htm.xml XML 4854
Mailing Address 44 MILTON AVENUE ALPHARETTA GA 30009
Business Address 44 MILTON AVENUE ALPHARETTA GA 30009 8666208655
Dogwood Therapeutics, Inc. (Filer) CIK: 0001818844 (see all company filings)

EIN.: 854314201 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39811 | Film No.: 251067053
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)